Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model.
Ontology highlight
ABSTRACT: Aims
Cardiovascular disease is a major threat to maternal health, with cardiomyopathy being among the most common acquired cardiovascular diseases during pregnancy and the postpartum period. The aim of our study was to evaluate the effectiveness of an electrocardiogram (ECG)-based deep learning model in identifying cardiomyopathy during pregnancy and the postpartum period.Methods and results
We used an ECG-based deep learning model to detect cardiomyopathy in a cohort of women who were pregnant or in the postpartum period seen at Mayo Clinic. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. We compared the diagnostic probabilities of the deep learning model with natriuretic peptides and a multivariable model consisting of demographic and clinical parameters. The study cohort included 1807 women; 7%, 10%, and 13% had left ventricular ejection fraction (LVEF) of 35% or less, <45%, and <50%, respectively. The ECG-based deep learning model identified cardiomyopathy with AUCs of 0.92 (LVEF ≤ 35%), 0.89 (LVEF < 45%), and 0.87 (LVEF < 50%). For LVEF of 35% or less, AUC was higher in Black (0.95) and Hispanic (0.98) women compared to White (0.91). Natriuretic peptides and the multivariable model had AUCs of 0.85 to 0.86 and 0.72, respectively.Conclusions
An ECG-based deep learning model effectively identifies cardiomyopathy during pregnancy and the postpartum period and outperforms natriuretic peptides and traditional clinical parameters with the potential to become a powerful initial screening tool for cardiomyopathy in the obstetric care setting.
SUBMITTER: Adedinsewo DA
PROVIDER: S-EPMC8715757 | biostudies-literature |
REPOSITORIES: biostudies-literature
Similar Datasets
Project description:ObjectivesBiosignal data captured by patient monitoring systems could provide key evidence for detecting or predicting critical clinical events; however, noise in these data hinders their use. Because deep learning algorithms can extract features without human annotation, this study hypothesized that they could be used to screen unacceptable electrocardiograms (ECGs) that include noise. To test that, a deep learning-based model for unacceptable ECG screening was developed, and its screening results were compared with the interpretations of a medical expert.MethodsTo develop and apply the screening model, we used a biosignal database comprising 165,142,920 ECG II (10-second lead II electrocardiogram) data gathered between August 31, 2016 and September 30, 2018 from a trauma intensive-care unit. Then, 2,700 and 300 ECGs (ratio of 9:1) were reviewed by a medical expert and used for 9-fold cross-validation (training and validation) and test datasets. A convolutional neural network-based model for unacceptable ECG screening was developed based on the training and validation datasets. The model exhibiting the lowest cross-validation loss was subsequently selected as the final model. Its performance was evaluated through comparison with a test dataset.ResultsWhen the screening results of the proposed model were compared to the test dataset, the area under the receiver operating characteristic curve and the F1-score of the model were 0.93 and 0.80 (sensitivity = 0.88, specificity = 0.89, positive predictive value = 0.74, and negative predictive value = 0.96).ConclusionsThe deep learning-based model developed in this study is capable of detecting and screening unacceptable ECGs efficiently.
| S-EPMC6689506 | biostudies-literature
Project description:(1) Background: Acute pericarditis is often confused with ST-segment elevation myocardial infarction (STEMI) among patients presenting with acute chest pain in the emergency department (ED). Since a deep learning model (DLM) has been validated to accurately identify STEMI cases via 12-lead electrocardiogram (ECG), this study aimed to develop another DLM for the detection of acute pericarditis in the ED. (2) Methods: This study included 128 ECGs from patients with acute pericarditis and 66,633 ECGs from patients visiting the ED between 1 January 2010 and 31 December 2020. The ECGs were randomly allocated based on patients to the training, tuning, and validation sets, at a 3:1:1 ratio. We used raw ECG signals to train a pericarditis-DLM and used traditional ECG features to train a machine learning model. A human-machine competition was conducted using a subset of the validation set, and the performance of the Philips automatic algorithm was also compared. STEMI cases in the validation set were extracted to analyze the DLM ability of differential diagnosis between acute pericarditis and STEMI using ECG. We also followed the hospitalization events in non-pericarditis cases to explore the meaning of false-positive predictions. (3) Results: The pericarditis-DLM exceeded the performance of all participating human experts and algorithms based on traditional ECG features in the human-machine competition. In the validation set, the pericarditis-DLM could detect acute pericarditis with an area under the receiver operating characteristic curve (AUC) of 0.954, a sensitivity of 78.9%, and a specificity of 97.7%. However, our pericarditis-DLM also misinterpreted 10.2% of STEMI ECGs as pericarditis cases. Therefore, we generated an integrating strategy combining pericarditis-DLM and a previously developed STEMI-DLM, which provided a sensitivity of 73.7% and specificity of 99.4%, to identify acute pericarditis in patients with chest pains. Compared to the true-negative cases, patients with false-positive results using this strategy were associated with higher risk of hospitalization within 3 days due to cardiac disorders (hazard ratio (HR): 8.09; 95% confidence interval (CI): 3.99 to 16.39). (4) Conclusions: The AI-enhanced algorithm may be a powerful tool to assist clinicians in the early detection of acute pericarditis and differentiate it from STEMI using 12-lead ECGs.
| S-EPMC9324403 | biostudies-literature
Project description:ObjectivesMany deep learning-based predictive models evaluate the waveforms of electrocardiograms (ECGs). Because deep learning-based models are data-driven, large and labeled biosignal datasets are required. Most individual researchers find it difficult to collect adequate training data. We suggest that transfer learning can be used to solve this problem and increase the effectiveness of biosignal analysis.MethodsWe applied the weights of a pretrained model to another model that performed a different task (i.e., transfer learning). We used 2,648,100 unlabeled 8.2-second-long samples of ECG II data to pretrain a convolutional autoencoder (CAE) and employed the CAE to classify 12 ECG rhythms within a dataset, which had 10,646 10-second-long 12-lead ECGs with 11 rhythm labels. We split the datasets into training and test datasets in an 8:2 ratio. To confirm that transfer learning was effective, we evaluated the performance of the classifier after the proposed transfer learning, random initialization, and two-dimensional transfer learning as the size of the training dataset was reduced. All experiments were repeated 10 times using a bootstrapping method. The CAE performance was evaluated by calculating the mean squared errors (MSEs) and that of the ECG rhythm classifier by deriving F1-scores.ResultsThe MSE of the CAE was 626.583. The mean F1-scores of the classifiers after bootstrapping of 100%, 50%, and 25% of the training dataset were 0.857, 0.843, and 0.835, respectively, when the proposed transfer learning was applied and 0.843, 0.831, and 0.543, respectively, after random initialization was applied.ConclusionsTransfer learning effectively overcomes the data shortages that can compromise ECG domain analysis by deep learning.
| S-EPMC7921576 | biostudies-literature
Project description:Myocardial infarction is a common cardiovascular disorder caused by prolonged ischemia, and early diagnosis of myocardial infarction (MI) is critical for lifesaving. ECG is a simple and non-invasive approach in MI detection, localization, diagnosis, and prognosis. Population-based screening with ECG can detect MI early and help prevent it but this method is too labor-intensive and time-consuming to carry out in practice unless artificial intelligence (AI) would be able to reduce the workload. Recent advances in using deep learning (DL) for ECG screening might rekindle this hope. This review aims to take stock of 59 major DL studies applied to the ECG for MI detection and localization published in recent 5 years, covering convolutional neural network (CNN), long short-term memory (LSTM), convolutional recurrent neural network (CRNN), gated recurrent unit (GRU), residual neural network (ResNet), and autoencoder (AE). In this period, CNN obtained the best popularity in both MI detection and localization, and the highest performance has been obtained from CNN and ResNet model. The reported maximum accuracies of the six different methods are all beyond 97%. Considering the usage of different datasets and ECG leads, the network that trained on 12 leads ECG data of PTB database has obtained higher accuracy than that on smaller number leads data of other datasets. In addition, some limitations and challenges of the DL techniques are also discussed in this review.
| S-EPMC8990170 | biostudies-literature
Project description:ObjectivesWith the attention paid to the early diagnosis of depression, this study tries to use the biological information of speech, combined with deep learning to build a rapid binary-classification model of depression in the elderly who use Mandarin and test its effectiveness.MethodsDemographic information and acoustic data of 56 Mandarin-speaking older adults with major depressive disorder (MDD), diagnosed with the Mini-International Neuropsychiatric Interview (MINI) and the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and 47 controls was collected. Acoustic data were recorded using different smart phones and analyzed by deep learning model which is developed and tested on independent validation set. The accuracy of the model is shown by the ROC curve.ResultsThe quality of the collected speech affected the accuracy of the model. The initial sensitivity and specificity of the model were respectively 82.14% [95%CI, (70.16-90.00)] and 80.85% [95%CI, (67.64-89.58)].ConclusionThis study provides a new method for rapid identification and diagnosis of depression utilizing deep learning technology. Vocal biomarkers extracted from raw speech signals have high potential for the early diagnosis of depression in older adults.
| S-EPMC9677587 | biostudies-literature
Project description:IntroductionCirrhosis is associated with cardiac dysfunction and distinct electrocardiogram (ECG) abnormalities. This study aimed to develop a proof-of-concept deep learning-based artificial intelligence (AI) model that could detect cirrhosis-related signals on ECG and generate an AI-Cirrhosis-ECG (ACE) score that would correlate with disease severity.MethodsA review of Mayo Clinic's electronic health records identified 5,212 patients with advanced cirrhosis ≥18 years who underwent liver transplantation at the 3 Mayo Clinic transplant centers between 1988 and 2019. The patients were matched by age and sex in a 1:4 ratio to controls without liver disease and then divided into training, validation, and test sets using a 70%-10%-20% split. The primary outcome was the performance of the model in distinguishing patients with cirrhosis from controls using their ECGs. In addition, the association between the ACE score and the severity of patients' liver disease was assessed.ResultsThe model's area under the curve in the test set was 0.908 with 84.9% sensitivity and 83.2% specificity, and this performance remained consistent after additional matching for medical comorbidities. Significant elevations in the ACE scores were seen with increasing model for end-stage liver disease-sodium score. Longitudinal trends in the ACE scores before and after liver transplantation mirrored the progression and resolution of liver disease.DiscussionThe ACE score, a deep learning model, can accurately discriminate ECGs from patients with and without cirrhosis. This novel relationship between AI-enabled ECG analysis and cirrhosis holds promise as the basis for future low-cost tools and applications in the care of patients with liver disease.
| S-EPMC9727935 | biostudies-literature
Project description:BackgroundCurrent electrocardiogram (ECG) criteria of left ventricular hypertrophy (LVH) have low sensitivity. Deep learning (DL) techniques have been widely used to detect cardiac diseases due to its ability of automatic feature extraction of ECG. However, DL was rarely applied in LVH diagnosis. Our study aimed to construct a DL model for rapid and effective detection of LVH using 12-lead ECG.MethodsWe built a DL model based on convolutional neural network-long short-term memory (CNN-LSTM) to detect LVH using 12-lead ECG. The echocardiogram and ECG of 1,863 patients obtained within 1 week after hospital admission were analyzed. Patients were evenly allocated into 3 sets at 3:1:1 ratio: the training set (n = 1,120), the validation set (n = 371) and the test set 1 (n = 372). In addition, we recruited 453 hospitalized patients into the internal test set 2. Different DL model of each subgroup was developed according to gender and relative wall thickness (RWT).ResultsThe LVH was predicted by the CNN-LSTM model with an area under the curve (AUC) of 0.62 (sensitivity 68%, specificity 57%) in the test set 1, which outperformed Cornell voltage criteria (AUC: 0.57, sensitivity 48%, specificity 72%) and Sokolow-Lyon voltage (AUC: 0.51, sensitivity 14%, specificity 96%). In the internal test set 2, the CNN-LSTM model had a stable performance in predicting LVH with an AUC of 0.59 (sensitivity 65%, specificity 57%). In the subgroup analysis, the CNN-LSTM model predicted LVH by 12-lead ECG with an AUC of 0.66 (sensitivity 72%, specificity 60%) for male patients, which performed better than that for female patients (AUC: 0.59, sensitivity 50%, specificity 71%).ConclusionOur study established a CNN-LSTM model to diagnose LVH by 12-lead ECG with higher sensitivity than current ECG diagnostic criteria. This CNN-LSTM model may be a simple and effective screening tool of LVH.
| S-EPMC9406285 | biostudies-literature
Project description:Cardiovascular diseases (CVDs) have become the number 1 threat to human health. Their numerous complications mean that many countries remain unable to prevent the rapid growth of such diseases, although significant health resources have been invested toward their prevention and management. Electrocardiogram (ECG) is the most important non-invasive physiological signal for CVD screening and diagnosis. For exploring the heartbeat event classification model using single- or multiple-lead ECG signals, we proposed a novel deep learning algorithm and conducted a systemic comparison based on the different methods and databases. This new approach aims to improve accuracy and reduce training time by combining the convolutional neural network (CNN) with the bidirectional long short-term memory (BiLSTM). To our knowledge, this approach has not been investigated to date. In this study, Database I with single-lead ECG and Database II with 12-lead ECG were used to explore a practical and viable heartbeat event classification model. An evolutionary neural system approach (Method I) and a deep learning approach (Method II) that combines CNN with BiLSTM network were compared and evaluated in processing heartbeat event classification. Overall, Method I achieved slightly better performance than Method II. However, Method I took, on average, 28.3 h to train the model, whereas Method II needed only 1 h. Method II achieved an accuracy of 80, 82.6, and 85% compared with the China Physiological Signal Challenge 2018, PhysioNet Challenge 2017, and Massachusetts Institute of Technology-Beth Israel Hospital (MIT-BIH) Arrhythmia datasets, respectively. These results are impressive compared with the performance of state-of-the-art algorithms used for the same purpose.
| S-EPMC7566908 | biostudies-literature
Project description:The goal of this research is to develop and implement a highly effective deep learning model for detecting COVID-19. To achieve this goal, in this paper, we propose an ensemble of Convolutional Neural Network (CNN) based on EfficientNet, named ECOVNet, to detect COVID-19 from chest X-rays. To make the proposed model more robust, we have used one of the largest open-access chest X-ray data sets named COVIDx containing three classes-COVID-19, normal, and pneumonia. For feature extraction, we have applied an effective CNN structure, namely EfficientNet, with ImageNet pre-training weights. The generated features are transferred into custom fine-tuned top layers followed by a set of model snapshots. The predictions of the model snapshots (which are created during a single training) are consolidated through two ensemble strategies, i.e., hard ensemble and soft ensemble, to enhance classification performance. In addition, a visualization technique is incorporated to highlight areas that distinguish classes, thereby enhancing the understanding of primal components related to COVID-19. The results of our empirical evaluations show that the proposed ECOVNet model outperforms the state-of-the-art approaches and significantly improves detection performance with 100% recall for COVID-19 and overall accuracy of 96.07%. We believe that ECOVNet can enhance the detection of COVID-19 disease, and thus, underpin a fully automated and efficacious COVID-19 detection system.
| S-EPMC8176542 | biostudies-literature
Project description:BackgroundElectrocardiogram (ECG) signal classification plays a critical role in the automatic diagnosis of heart abnormalities. While most ECG signal patterns cannot be recognized by a human interpreter, they can be detected with precision using artificial intelligence approaches, making the ECG a powerful non-invasive biomarker. However, performing rapid and accurate ECG signal classification is difficult due to the low amplitude, complexity, and non-linearity. The widely-available deep learning (DL) method we propose has presented an opportunity to substantially improve the accuracy of automated ECG classification analysis using rhythm or beat features. Unfortunately, a comprehensive and general evaluation of the specific DL architecture for ECG analysis across a wide variety of rhythm and beat features has not been previously reported. Some previous studies have been concerned with detecting ECG class abnormalities only through rhythm or beat features separately.MethodsThis study proposes a single architecture based on the DL method with one-dimensional convolutional neural network (1D-CNN) architecture, to automatically classify 24 patterns of ECG signals through both rhythm and beat. To validate the proposed model, five databases which consisted of nine-class of ECG-base rhythm and 15-class of ECG-based beat were used in this study. The proposed DL network was applied and studied with varying datasets with different frequency samplings in intra and inter-patient scheme.ResultsUsing a 10-fold cross-validation scheme, the performance results had an accuracy of 99.98%, a sensitivity of 99.90%, a specificity of 99.89%, a precision of 99.90%, and an F1-score of 99.99% for ECG rhythm classification. Additionally, for ECG beat classification, the model obtained an accuracy of 99.87%, a sensitivity of 96.97%, a specificity of 99.89%, a precision of 92.23%, and an F1-score of 94.39%. In conclusion, this study provides clinicians with an advanced methodology for detecting and discriminating heart abnormalities between different ECG rhythm and beat assessments by using one outstanding proposed DL architecture.
| S-EPMC8802771 | biostudies-literature